Skip to main content
Download PDF

Correction to: Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage–related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial

Journal of Intensive Care volume 8, Article number: 66 (2020) Cite this article

The Original Article was published on 04 May 2020

Correction to: J Intensive Care 8, 32 (2020)

https://doi.org/10.1186/s40560-020-00449-0

Following the publication of the original article [1], it was noted that Fig. 3b had an erroneous graph. The correct Fig. 3 has been included in this correction. The authors apologize for this error.

Fig. 3
figure 1

The effect of hypertonic solution on renal function and ICP reduction. a The rate of AKI was lower in the NaCl/Na-acetate group as compared with the NaCl group in an intention to treat analysis. b Comparison of Na+/Cl− loads with the study intervention doses, post-randomization. c Histogram of AKI frequency by group of treatment and hospitalization day. *p < 0.05. AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes grading for AKI

Full size image

Reference

  1. Sadan O, et al. Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage–related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial. J Intensive Care. 2020;8:32. https://doi.org/10.1186/s40560-020-00449-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Neurosurgery, Division of Neurocritical Care, Emory University Hospital and Emory University School of Medicine, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA

    Ofer Sadan, Jacqueline Kraft, Joao McONeil Plancher, Prem Kandiah, Cederic Pimentel, C. L. Hall & Owen Samuels

  2. Department of Critical Care Medicine, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA

    Kai Singbartl

  3. School of Medicine, Emory University, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA

    Alexander C. M. Greven

  4. Department of Anesthesiology, Emory University Hospital and Emory University School of Medicine, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA

    Alexander Papangelou

  5. Department of Pharmacy, Emory University Hospital, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA

    William H. Asbury

  6. Department of Biostatistics and Bioinformatics, Emory University, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA

    John J. Hanfelt

Authors
  1. Ofer Sadan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Singbartl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacqueline Kraft
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joao McONeil Plancher
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander C. M. Greven
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prem Kandiah
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cederic Pimentel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. L. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alexander Papangelou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. William H. Asbury
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John J. Hanfelt
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Owen Samuels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ofer Sadan.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadan, O., Singbartl, K., Kraft, J. et al. Correction to: Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage–related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial. j intensive care 8, 66 (2020). https://doi.org/10.1186/s40560-020-00485-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40560-020-00485-w

Journal of Intensive Care

ISSN: 2052-0492